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Abstract Phase variation through slippage-like mechanisms
involving homopolymeric tracts depends in part on the absence of
Dam-methylase in several pathogenic isolates of Neisseria
meningitidis. In Dam-defective strains drg (dam-replacing gene),
flanked by pseudo-transposable small repeated elements (SREs),
replaced dam. We demonstrate that drg encodes a restriction
endonuclease (NmeBII) that cleaves 5P-GmeATC-3P. drg is also
present in 50% of Neisseria lactamica strains, but in most of
them it is inactive because of the absence of an SRE-providing
promoter. This is associated with the presence of GATmeC,
suggesting an alternative restriction-modification system (RM)
specific for 5P-GATC-3P, similar to Sau3AI-RM of Staphylo-
coccus aureus 3A, Lactococcus lactis KR2 and Listeria
monocytogenes. ß 2001 Published by Elsevier Science B.V.
on behalf of the Federation of European Biochemical Societies.
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1. Introduction
Neisseria meningitidis, a narrow-host-range parasite, under-
goes sophisticated genetic switches for adapting to di¡erent
microenvironments within the human host during the course
of a natural infection. Control of retrievable genetic pro-
grammes by phase variation of several surface-associated
components including capsule and outer membrane proteins
enables the microorganism to choose between alternative life
styles, commensal or pathogenic, intracellular or extracellular,
and to evade the host immune system. The genetic basis for
this variation depends on the evolution of iterative DNA mo-
tifs, especially homopolymeric tracts, to e¡ect reversible, high-
frequency molecular switching through slippage-like mecha-
nisms [1]. We have recently clari¢ed several aspects of the
molecular mechanism responsible for phase variation by
slipped-strand mispairing involving homopolymeric repeats
[2]. Although the mutation rate at homopolymeric repeats is
high in all strains, several strains isolated from patients may
be hypermutable at these loci due in part to genetic defects in
the DNA mismatch repair process. Molecular analysis showed
that the mutator phenotype depends on the absence of activity
of the Dam-methylase, a component of the methyl-directed
mismatch repair system [3], evolutionarily conserved along
phylogenesis of the Q subgroup of the Proteobacteria, includ-
ing Vibrio, Haemophilus, and Escherichia [4^6], present in
Neisseria, belonging to the strictly related L subgroup [2],
and also found in the spirochete Treponema pallidum [7].
The analysis of the meningococcal dam gene region revealed
that in all Dam-defective strains a gene, named drg (dam-re-
placing gene), bordered by pseudo-transposable neisserial
small repetitive elements (SRE) [8] replaced the functional
dam gene. The putative gene product shared signi¢cant ho-
mology (44.5% identity and 66.9% similarity) with the Strep-
tococcus pneumoniae type II restriction endonuclease DpnI,
which cleaves the GATC sequence methylated at the adenine
residue. On the basis of this and other indirect evidence, it was
inferred that the product of drg was a restriction endonu-
clease, and that the dam and drg genes were mutually exclu-
sive. In this paper we have investigated the function of the drg
gene product, and have analysed the presence of drg in non-
pathogenic Neisseria in an attempt to gain more information
about its origin and evolution during speciation.
2. Materials and methods
2.1. Bacterial strains and growth conditions
Neisseria strains (Table 1) were cultured on GC agar or broth
supplemented with 1% (v/v) Polyvitox (Bio-Merieux) at 37‡C in 5%
CO2. When required rifampicin (36 Wg/ml) was added.
Escherichia coli strain SMR843 (dam13 : :Tn9) and congenic
SMR506 (wild type) were a gift of Dr. S.M. Rosenberg (University
of Alberta, Canada). E. coli strains were grown in Luria^Bertani
broth supplemented with ampicillin (50 Wg/ml), when required.
2.2. Plasmids and cloning procedures
Plasmid pUC-Drg was constructed by cloning a 960-bp HindIII^
BamHI fragment, spanning the coding region of drg, into pUC19. The
960-bp fragment was obtained by amplifying a genomic region from
strain BL859 by polymerase chain reaction (PCR) using the oligonu-
cleotides 5P-AATCCAAAGCTTGAATTTATTTTTCGATACCAA-
ATTGG-3P and 5P-AGCGGCGGATCCGGCAGCTTCTTCAGCC-
GGTTTGTC-3P.
2.3. DNA procedures
Genomic DNA from Neisseria strains was prepared as described
[9]. DNA fragments were isolated through polyacrylamide slab gels
and recovered by electroelution [10].
DNA labelling and Southern blot experiments were performed ac-
cording to Sambrook et al. [10]. A 1-kb DNA ladder (Life Technol-
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ogies) was used as a molecular weight marker. The 32P-labelled 960-bp
HindIII^BamHI fragment was used as a drg-speci¢c probe.
DNA sequencing reactions were carried out by the dideoxy chain
termination procedure using a PCR-based methodology. The oligonu-
cleotides used to amplify the leuS^drg region were 5-AGTGA-
TGGTTCAAGTCAACGGCAAACTGCG-3P and 5P-CGTATTCG-
GCAGCTTCTTCAGCCGGTTTGTC-3P.
The ampli¢cation consisted of 30 cycles of 1 min at 94‡C, 1 min at
55‡C and 1^2 min at 72‡C and was performed in a Perkin Elmer
Thermal Cycler 480.
2.4. RNA Procedures
Total RNA was extracted from logarithmically growing cells by the
guanidine hydrochloride procedure [2]. Electrophoretic analysis was
done by fractionating the total RNA on 1% agarose gels containing
formaldehyde [10]. RNA transfer to Hybond (Amersham) membranes
and hybridisation were according to standard procedures [10].
2.5. Transformation of meningococci
Transformations were performed as described [11] with 500 ng of
chromosomal DNA extracted from rifampicin-resistant derivatives of
strains BL847 or BF52. The recipient strain was BF52. Transformants
were selected on GC agar supplemented with rifampicin.
2.6. Extract preparation
Logarithmically growing cells (OD550 = 0.5, 200 ml) in LB medium
were induced with 0.5 mM isopropyl-L-D-thiogalactopyranoside
(IPTG) for 45^90 min at 37‡C. Cells were harvested by centrifugation
at 5000Ug, resuspended in 4 ml of 50 mM Tris^HCl (pH 8) contain-
ing 1 mM phenylmethylsulfonyl £uoride, and broken by a French
press. Crude extracts were centrifuged at 30 000Ug for 30 min and
the supernatants were collected and frozen at 380‡C. S30 extracts
were analysed by SDS^PAGE as described [10]. Protein molecular
weight ladders (Rainbow 800) were from Amersham.
2.7. Assays for NmeBII activity
S30 extracts derived from IPTG-induced E. coli cells harbouring
pUC-Drg (expressing NmeBII) or pUC19 were added to 20 Wl reac-
tion mixture containing 10 mM Tris^HCl, pH 7.6, 50 mM NaCl,
10 mM MgCl2, 10 mM 2-mercaptoethanol, 1 mg/ml of bovine serum
albumin and 1 Wg of Dam+ or Dam3 DNAs derived from rifampicin-
resistant strains. After incubation for 2 h at 37‡C, transformation
activity was assayed on the rifampicin-sensitive strains BF52. Trans-
formants were scored by plating 106 colony-forming units (CFU) on
selective plates; in control cultures no rifampicin-resistant clones were
detected by plating 106 CFU. A relative transforming activity equal to
1 corresponds to a transformation e⁄ciency of 3.5U1034. Endonu-
clease activity was tested using pUC19-puri¢ed DNA.
3. Results and discussion
3.1. Function of the N. meningitidis drg gene
The coding sequence of drg was ampli¢ed by PCR from
strain BL859, and cloned into pUC19 translationally in frame
with lacZ, under expression of the IPTG-inducible lac pro-
moter. Cloning was viable in a dam-defective E. coli host
Table 1
Neisseria strains
Strain Drga Dam phenotypeb Sau3AI restrictionc Sourced
N. meningitidis
BL859 + 3 S i
BL847 + 3 S i
B1940 + 3 S ii
BL911 + 3 S iii
BF2 3 + S iv
BF9 3 + S iv
BF52 3 + S v
BF18 + 3 S v
N. lactamica
NL21 3 3 R iii
NL56 3 + S iii
NL76 3 + S iii
NL104 + 3 R iii
NL172 3 + S iii
NL411 + 3 R iii
NL995 + 3 S iii
NL4627 + 3 R iii
N. mucosa
NM404 3 3 S iv
NM405 3 3 S iii
N. sicca
NS407 3 + S iv
NS408 3 + S iii
N. £ava
NF410 3 + S iii
NF3264 3 + S iii
N. sub£ava
NS3260 3 + S iii
NS5291 3 + S iii
N. cinerea
NC415 3 3 S iii
NC5917 3 3 S iii
aThe presence of drg was investigated by Southern blot (Fig. 2).
bThe Dam phenotype was determined by treating the chromosomal DNAs with isoschizomers MboI and DpnI which cleave the GATC se-
quence depending on the adenine methylation status, MboI cutting only non-methylated sites, and DpnI cutting only methylated sequences.
cS, sensitive to restriction by Sau3AI; R, resistant to restriction.
di : Istituto Superiore di Sanita', Rome, Italy; ii : Bayerische Julius-Maximilians Universita«t, Wu«rzburg, Germany; iii : CNRM, Institut Pasteur,
Paris, France; iv: II Policlinico, Universita' di Napoli, Naples, Italy; v: Ho“pital d’Instruction des Arme¤e, Brest, France.
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(SMR843) and led to generation of recombinant pUC-Drg.
Expression of Drg protein in E. coli S30 extracts was checked
by SDS^PAGE (Fig. 1A). This analysis evidenced a protein of
about 31.5 kDa, very close to the expected size (31.482 kDa),
in IPTG-induced cells (Fig. 1A, lanes 4 and 5), absent in non-
induced cells (Fig. 1A, lane 3) or in control cells harbouring
the vector (Fig. 1A, lanes 1 and 2).
To have preliminary evidence of the activity of Drg, a
transformation experiment was performed using a N. menin-
gitidis Dam+ strain, and Dam-methylated or non-methylated
DNA puri¢ed from rifampicin-resistant Dam+ or Dam3
strains (Dam+ or Dam3 RifR DNA). This experiment tested
the ability of the extract containing the Drg protein to inhibit
the transforming activity by RifR DNA (Fig. 1B). Dam+ and
Dam3 RifR DNAs were therefore pre-treated with amounts
of extracts derived from IPTG-induced E. coli cells harbour-
ing pUC-Drg or pUC19. This experiment demonstrated that
the S30 extract expressing Drg was able to inhibit the trans-
forming activity of the Dam+ RifR DNA. The level of inhi-
bition was dependent on the amounts of extract added. In
contrast, the extract was not e¡ective on Dam3 RifR DNA.
pUC19 extracts did not inhibit transformation by either
Dam+ or Dam3 RifR DNA. These data indicated that re-
combinant Drg retained biological activity, and they are con-
sistent with the hypothesis that Drg encodes a type II restric-
tion endonuclease cleaving the Dam-methylated GmeATC
sequence.
Direct evidence of the activity of the Drg protein was ob-
tained by restriction analysis (Fig. 1C). pUC19 DNA derived
from Dam+ or Dam3 strains (Fig. 1C, lanes 1 and 9, respec-
tively) was treated with various amounts of pUC-Drg or
pUC19 extracts. As a control, pUC19 DNA was digested
Fig. 1. A: Expression of recombinant drg. E. coli strain SMR843
harbouring pUC19 (lanes 1 and 2) or pUC-Drg (lanes 3^5) were in-
duced with IPTG for 45 min (lanes 2 and 4), 90 min (lane 5), or
not induced (lanes 1 and 3). S30 extracts were run on 12% SDS^
PAGE. Bars, molecular weight ladders. Arrow, induced 31.5-kDa
polypeptide. B: Action of endonuclease NmeBII on Dam+ and
Dam3 transforming DNA. Closed circles, Dam+ DNA pre-treated
with NmeBII extract; open circles, Dam+ DNA pre-treated with
control extract; closed squares, Dam3 DNA pre-treated with Nme-
BII extract; open squares, Dam3 DNA pre-treated with control ex-
tract. C: Site and DNA adenine methylation speci¢city of endonu-
clease NmeBII. pUC19 plasmid DNA, derived from either Dam-
pro¢cient (lanes 1^8) or Dam-defective (lanes 9^16) strains, was in-
cubated in the presence of increasing amounts (2.5, 5, or 7.5 Wg) of
NmeBII extract (lanes 3^5 and 11^13) or control extract (lanes 6^8
and 14^16). As a control, the pUC19 DNA (lanes 1 and 9) was di-
gested with Sau3AI (lanes 2 and 10). Molecular weight ladders were
run in parallel (M).
Fig. 2. Southern blot analysis of drg in pathogenic and non-patho-
genic Neisseriae. HinfI-restricted chromosomal DNAs derived from
two Drg3 (lanes 1 and 2) and from two Drg+ (lanes 3 and 4)
N. meningitidis strains, from eight N. lactamica strains (Fig. 3, lanes
5^12), and from pairs of N. mucosa, N. sicca, N. £ava, N. sub£ava
and N. cinerea strains (Fig. 3, lanes 13^22) were hybridised to a
drg-speci¢c probe. The name of each individual strain is indicated
above the respective lane. Bars, molecular weight ladders.
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with Sau3AI, which cleaves the GATC sequence irrespective
of the adenine methylation status (Fig. 1C, lanes 2 and 10).
Treatment of Dam+ pUC19 DNA with the extract containing
Drg (Fig. 1C, lanes 3^5) resulted in the appearance of cleav-
age products corresponding in size to those obtained with
Sau3AI. In contrast, Dam3 pUC19 DNA was not digested
by the extract (Fig. 1C, lanes 11^13). Digestion products were
not observed with the control extract either on Dam+ or on
Dam3 plasmid DNA (Fig. 1C, lanes 6^8 and 14^16, respec-
tively). This result con¢rmed the cutting speci¢city of the drg
gene product, now named NmeBII.
3.2. Evolution of the N. meningitidis drg gene
The analysis of the structure of the N. meningitidis leuS^
dam region evidenced that all strains belong to alternative
biotypes: strains harbouring an intact dam gene, and strains
harbouring an identical rearrangement removing part of the
dam gene, possibly promoted by pseudo-transposable SRE
elements bordering the mutually exclusive drg gene [2]. This
evidence suggested (i) that the dam-pro¢cient biotype was the
ancestral one, (ii) that drg came from outside, and (iii) that
the rearrangement leading to introduction of drg into the
leuS^dam region occurred during evolution of several menin-
gococcal pathogenic lineages and/or during speciation of
pathogenic Neisseria. In fact, there is evidence that the same
rearrangement is also present in several strains of N. gonor-
rhoeae (strain FA1090, University of Oklahoma). To investi-
gate in more detail the origin and evolution of drg, and its
distribution among pathogenic and non-pathogenic Neisseria
species, a Southern blot experiment was performed (Fig. 2).
To this purpose, HinfI-restricted chromosomal DNAs derived
from Neisseria lactamica (Fig. 2, lanes 5^12), from pairs of
Fig. 3. Comparison of nucleotide sequences of the leuS^drg region from N. meningitidis and N. lactamica strains. The nucleotide sequences of
the leuS^drg genetic region from N. meningitidis strains BS847, B1940, BL915, BL859 and from N. lactamica strain NL4627 are aligned. Dots,
identical nucleotides; tracts, missing nucleotides. Start and stop codons of drg are underlined. Arrows, palindromic sequences that are part of
the neisserial uptake sequence (US), and SRE. The nucleotide sequence between the two closed triangles is present in Dam3 Drg+ strains and
absent in Dam+ isolates.
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Neisseria mucosa, Neisseria sicca, Neisseria £ava, Neisseria
sub£ava and Neisseria cinerea (Fig. 2, lanes 13^22), and
from N. meningitidis Drg3 (Fig. 2, lanes 1 and 2) or Drg+
(Fig. 2, lanes 3 and 4) strains were hybridised to a drg-speci¢c
probe. Speci¢c DNA fragments were detected in four out of
eight N. lactamica strains, but in none of the other non-patho-
genic Neisseriae (Fig. 2, lanes 13^22). More in detail, strains
NL104, NL411 and NL4627 (Fig. 2, lanes 8, 10 and 12, re-
spectively) exhibited fragments of similar size (about 2150 bp).
Strain NL995 (Fig. 2, lane 11) exhibited a fragment very close
in size to one of the two fragments detectable in the N. men-
ingitidis strain BF18 (Fig. 2, lane 4).
Consistently with previous observations in N. meningitidis
[2], the presence of drg was generally associated with the ab-
sence of Dam methylation also in N. lactamica. However, N.
lactamica NL21, N. mucosa NM404 and NM405, and N. cin-
erea NC415 and NC5917 strains were both Drg3 and Dam3
(Table 1). Signi¢cantly, the DNAs derived from Dam3
strains NL21, NL104, NL411 and NL4627, but not that de-
rived from NL995, from N. meningitidis, or from the other
non-pathogenic Neisseriae were resistant to restriction by
Sau3AI (Table 1). Cleavage by this enzyme is inhibited by
methylation at the cytosine residue within the target GATC
sequence [12]. We therefore speculate that several N. lactamica
strains have acquired a type II restriction-modi¢cation system
similar to that present in several Gram-positive bacteria in-
cluding Staphylococcus aureus 3A [12], Lactococcus lactis KR2
[13], Listeria monocytogenes [14]. This system does not seem to
be present in Dam+ N. lactamica strains.
More information about the evolution of drg was obtained
by nucleotide sequence analysis (Fig. 3). Regions of DNA
containing drg were sequenced from a N. lactamica strain
and from four serogroup B N. meningitidis strains of distinct
clonal types [2]. Comparison of the nucleotide sequences de-
rived from the meningococcal strains evidenced that drg was
highly variable. Indeed, we detected 37 polymorphic sites
within the coding regions, giving rise to distinct alleles with
diversity up to 2.65%. In contrast, dam was highly conserved
(we only found 10 polymorphic sites in three di¡erent alleles
and three di¡erent proteins, and a diversity up to 1.59%; data
not shown). The di¡erent results with the drg and dam genes
might re£ect functional constraints of the respective gene
products. Alternatively, variability of drg might result from
hyper-mutation, inherent in the presence of drg (and loss of
dam) within the mutator cell.
The diversity between drg genes from N. meningitidis and N.
lactamica was about the same order of magnitude. However,
the PCR and sequence analyses of the genomic DNA from
di¡erent strains (Fig. 3 and data not shown) revealed that, in
N. lactamica, drg was preceded by the SRE only in strain
NL995. The absence of the SRE might be the consequence
of excision of the element upon recombination involving the
terminal TATA sequences of the SRE [8]. The TA dinucleo-
tide in N. lactamica (Fig. 3) would represent a relic of the
recombinational event. Alternatively, pseudo-transposition of
SRE into the leuS^drg region was subsequent to the genomic
rearrangement replacing drg for the dam gene, and it speci¢-
cally occurred during speciation of meningococci. If the latter
hypothesis is correct, the TA dinucleotide would represent the
target site for pseudo-transposition. As a consequence, be-
cause the TA repeat borders SRE in most locations, the TA
dinucleotide should not be considered a part of the inverted
repeats (IRL and IRR) of the element [8], but a preferred
target site, which undergoes duplication upon pseudo-trans-
position.
Transcription of drg was believed to be promoted by se-
quences lying within the SRE [2,15]. Due to lack of SRE, in
most N. lactamica strains the drg coding region starts only 60
bp downstream of the putative transcription terminator of
leuS. In the 60-bp region obvious consensus sequences for
c70 are not detectable. Indeed, the results of Northern blot
experiments demonstrated that drg was transcriptionally ac-
tive in NL995 (harbouring the SRE upstream of drg) (Fig. 4,
lane 1), but not in NL4627 (lacking the SRE) (Fig. 4, lane 2).
Altogether these ¢ndings will be useful to clarify the structure
and the mechanisms responsible for pseudo-transposition of
the neisserial SRE, and provide additional evidence of its
nature of ‘mobile’ promoter.
In conclusion, our results demonstrate that drg, which is
associated with most serogroup B meningococci isolated
from patients, is present in about 50% of N. lactamica strains,
and that the same strains are defective in Dam-methylase
activity. These ¢ndings are consistent with the hypothesis
that a continuous horizontal £ow of genetic material a¡ects
the chromosomal composition not only of the pathogenic
Neisseria species, but also of many non-pathogenic species.
Genetic exchange between N. meningitidis and N. lactamica
is documented by several studies attempting to provide phy-
logeny of these organisms. A recent study, based on sequence
comparisons of housekeeping genes and the small subunit
(16S) rRNA, demonstrates that N. lactamica and N. meningi-
tidis are closely related species, and collocates them in one of
¢ve groups [16]. Indeed, N. lactamica and several serogroups
of N. meningitidis share similar structures and genetic ele-
ments, including lipooligosaccharide epitopes [17], porins
[18] and a cryptic plasmid [19], in addition to several meta-
bolic properties [20]. Moreover, among the non-pathogenic
Neisseriae, N. lactamica is the more frequently involved spe-
cies in human diseases [21^28]. Further studies will address
Fig. 4. Northern blot analysis of drg-speci¢c transcripts. Total
RNAs, extracted from N. lactamica strains NL995 (lane 1) and
NL4627 (lane 2), were hybridised to the drg-speci¢c probe. Arrow,
drg-speci¢c transcript. Bars, 23S and 16S rRNAs.
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the question whether the absence of Dam activity and/or the
presence of an alternative restriction-modi¢cation system spe-
ci¢c for the GATC sequence in N. lactamica has functional
consequences for mutation rates and regulation of phase-var-
iable genes, and plays a role in adaptation and, occasionally,
in pathogenesis.
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